Latest Selective estrogen receptor modulators Stories
- Prasco to market the Authorized Generic of EVISTA® in the United States CINCINNATI, April 1, 2014 /PRNewswire/ -- Prasco
Certain medications can reduce a woman's risk for developing breast cancer.
There is good news for postmenopausal women who are at high risk for developing breast cancer. According to a new study, taking the drug anastrozole for five years reduced the likelihood of developing the disease by 53 percent when compared with women who took a placebo.
In the eye, cataracts due to tamoxifen develop in about ten percent of patients taking the drug.
ASCO expert panel includes University of New England researcher Nananda Col, M.D., M.P.H. Biddeford, ME (PRWEB) July 16, 2013 The
New research from the Mayo Clinic has identified favorable genetic variations that increase the chances of a positive response to preventive breast cancer therapy with the drugs tamoxifen and raloxifene.
Researchers announced new findings that taking one breast cancer drug for twice the time suggested can substantially increase survival rates.
Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen.